Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy?
- 1 June 1989
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 59 (6), 910-914
- https://doi.org/10.1038/bjc.1989.192
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines.The Journal of Experimental Medicine, 1986
- Antibody guided irradiation of brain glioma by arterial infusion of radioactive monoclonal antibody against epidermal growth factor receptor and blood group A antigen.BMJ, 1985
- The human thymus microenvironment: heterogeneity detected by monoclonal anti-epithelial cell antibodies.1985
- Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.JCI Insight, 1983
- Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenesNature, 1983
- CELLULAR ONCOGENES AND RETROVIRUSESAnnual Review of Biochemistry, 1983
- Radioactive Labeling of Antibody: A Simple and Efficient MethodScience, 1983
- MONOCLONAL-ANTIBODY THERAPEUTIC TRIALS IN 7 PATIENTS WITH T-CELL LYMPHOMA1983
- RADIOIMMUNODETECTION OF HUMAN COLORECTAL CANCERS BY AN ANTI-TUMOUR MONOCLONAL ANTIBODYThe Lancet, 1982
- Identification of a T cell-derived b cell growth factor distinct from interleukin 2.The Journal of Experimental Medicine, 1982